Hudecek, Michael <br/><br/>
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity.  [electronic resource] 

 -  Cancer immunology research  Feb 2015 
 - 125-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-14-0127  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD19--immunology<br/>Burkitt Lymphoma--immunology<br/>Cell Death--immunology<br/>Cell Line, Tumor<br/>Cytotoxicity, Immunologic<br/>Genetic Engineering--methods<br/>Genetic Vectors<br/>Humans<br/>Immunoglobulin G--immunology<br/>Immunophenotyping--methods<br/>Immunotherapy, Adoptive--methods<br/>Lentivirus--genetics<br/>Lung--immunology<br/>Lymphocyte Activation--immunology<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Protein Structure, Tertiary<br/>Receptors, Antigen, T-Cell--immunology<br/>Recombinant Fusion Proteins--immunology<br/>Signal Transduction--immunology<br/>Structure-Activity Relationship<br/>T-Lymphocytes--immunology<br/>Xenograft Model Antitumor Assays